Impax hires new compliance officer; MIT continuous manufacturing start-up gets new home;

> Impax Laboratories ($IXPL) has named Deborah M. Penza, an Actavis alum, as chief compliance officer. Release

> Continuus Pharmaceuticals, which designs, builds and runs processes for the continuous manufacturing of small-molecule pharmaceuticals, and which grew from the collaboration between the Massachusetts Institute of Technology and Novartis ($NVS), has moved to Woburn, MA. Report

> A man with both U.K. and Pakistani citizenship has been indicted for operating websites that sold unapproved drugs that the sites claimed could cure a number of diseases. Release